Adding an SGLT2 inhibitor to standard care did not improve clinical outcomes in critically ill patients with acute organ dysfunction, an open-label randomized trial involving intensive care units ...
Sepsis, a common complication following burns, trauma, and major surgery, remains the leading cause of death among critically ill patients. Globally, there are about 48.9 million sepsis patients and ...
In January 2025, SeaStar Medical was awarded the 2025 Corporate Innovator Award by the National Kidney Foundation for its significant contribution to improving the lives of pediatric patients with AKI ...
The SOFA-2 score included new definitions, new variables, and revised thresholds to categorize the severity of organ dysfunction in critical illness. The updates reflected changes in practice, ...
Compared with placebo, a 72-hour infusion of 1 ng/kg/min iloprost does not improve outcomes or reduce the severity of organ failure among patients admitted to the intensive care unit (ICU) with septic ...
Validation of SOFA-2 score in sepsis and exploration of its extension with additional immune markers
The figure shows changes in the distribution of SOFA-1 and SOFA-2 scores, both overall and within each individual organ system domain. Sepsis, a life-threatening condition, remains a leading cause of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results